[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100484565":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":24,"locations":31,"responsibleParty":49,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":65,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"University Health Network, Toronto","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Stereotactic Radiotherapy (SBRT)",null,"Standard of care stereotactic radiotherapy.",[13],"Radiation: Radiotherapy",{"label":15,"type":10,"description":16,"interventionNames":17},"Conventional Radiotherapy (CRT)","Standard of care conventional radiotherapy.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"RADIATION","Radiotherapy","Standard of care radiotherapy administered as per institutional guidelines.",[15,9],[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"David Shultz, MD","CONTACT","416-946-4501","2121","david.shultz@rmp.uhn.ca",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"University Health Network","RECRUITING","Toronto","Ontario","M5G 1X6","Canada","CA",{"type":41,"coordinates":42},"Point",[43,44],-79.39864,43.70643,{"lat":44,"lon":43},[47],{"name":48,"role":27,"phone":28,"phoneExt":29,"email":30},"David Shultz, MD.",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100484565","comparing-sbrt-to-crt-in-patients-with-spinal-metastases-100484565",false,"NCT05589701","Comparing SBRT to CRT in Patients With Spinal Metastases","Prospective Registry Trail COMparing Stereotactic Body Radiotherpy (SBRT) to Conventional PAlliative RadioTherapy (CRT) in Patients With Spinal Metastases","COMBAT","Inclusion Criteria:\n\n* Adults 18 years of age or older.\n* Patients seen at the Princess Margaret Cancer Centre with painful spinal metastases amenable to radiation treatment.\n* Confirmation of diagnosis: a) Known\u002Fdocumented prior histological cancer diagnosis\n* Able to provide written consent\n* ECOG performance status 0-3\n\nExclusion Criteria:\n\n* Prior radiotherapy, with fields overlapping, resulting in excessive doses to organs at risk\n* Lymphoma, myeloma or germ cell malignancies","ALL","18 Years","100 Years",{"count":63,"type":64},100,"ESTIMATED","2 Years","OBSERVATIONAL","This is a single institutional registry-based, prospective, observational study to describe radiation oncologists' decision making during evaluation of patients and to compare real-world outcomes of SBRT vs CRT.\n\nA registry-based trial involves observing the effect of something without manipulating it.",[69],"Spinal Metastases","2026-03-03",{"date":72,"type":73},"2026-03-05","ACTUAL",{"date":75,"type":73},"2022-12-12",{"date":77,"type":64},"2027-12",{"name":5,"class":6},1]